Biotech Investors & VC Firms in Cambridge
41 firms in this list, with a median first check of $500K. 6 of them lead rounds. Generated from verified public data and updated continuously.
AbbVie
CambridgeSeed–Late Stage$300K – $3M
10 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
University of Cambridge Enterprise
CambridgePre-Seed–Late Stage
10 people
ETCapital
CambridgePre-Seed–Series A$100K – $952.5K
3 people
Start Codon
CambridgePre-Seed–Seed
2 people
FoundersX Ventures
CambridgeSeed
1 person
Saisei Ventures
CambridgePre-Seed–Growth
5 people
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
TTP Ventures
CambridgeSeed–Late Stage
Taihill Venture
BostonPre-Seed–Series A
7 people
Qiming Venture Partners USA
CambridgeSeed–Series A
2 people
Ceres Agri-Tech
CambridgePre-Seed–Seed
1 person
Curie.Bio
CambridgeSeed–Series A$7M
7 people
Cambridge Capital Group
CambridgePre-Seed–Growth
Oscar & Paul Beiersdorf Venture Capital
CambridgeSeed–Growth
2 people
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
Unveil Pharma
Cambridge
1 person
Related lists
Crypto & Web3 Investors & VC Firms (4673)Investors & VC Firms in United States (4534)Investors & VC Firms in Global (3593)SaaS Investors & VC Firms (3531)AI & Machine Learning Investors & VC Firms (3411)Fintech Investors & VC Firms (3409)Healthtech Investors & VC Firms (3095)Enterprise Software Investors & VC Firms (2998)Investors & VC Firms in Europe (2640)Consumer Investors & VC Firms (2310)
Data sourced from public filings and firms' own websites — see our methodology.













